Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Clinical Immunology · C1r/C1s Deficiency

Building Your Foundation: Understanding C1r/C1s Deficiency

At a Glance

Complete C1r/C1s deficiency is a rare complement disorder that can raise the risk of serious infections and lupus-like autoimmunity. CH50 and AH50 testing, vaccination, kidney monitoring, and specialist care help guide evaluation and ongoing management.

C1r/C1s deficiency is an exceptionally rare condition that affects the very beginning of your immune system’s complement system [1]. The complement system is a group of proteins in your blood that “complement” the work of antibodies to clear out bacteria and dead cells [2].

Because this condition is so rare—with evidence drawn largely from small families and case reports—it is often misunderstood [1]. Many patients go through a “diagnostic odyssey,” spending years being treated for standard Systemic Lupus Erythematosus (SLE) or recurrent infections before a doctor thinks to check their specific complement levels [3][4].

How the C1 Complex Works

To understand this deficiency, it helps to look at the classical pathway, which is the first step in a chain reaction of immune defense. This pathway starts with the C1 complex, a structure made of three parts:

  • C1q: The “sensor” that recognizes invaders or damaged cells [5].
  • C1r and C1s: The “engines” (proteases) that activate the rest of the system [2].

When C1q finds a target, it activates C1r and C1s. They then go on to chop up other proteins (C4 and C2), starting a cascade that helps your body kill bacteria and “clean up” the debris of dying cells [5][6]. If you have a confirmed complete C1r or C1s deficiency, this entire cleanup and defense activation line is essentially broken from the start, though your alternative and lectin pathways remain available [7].

Two Major Reported Risks: Infections and Autoimmunity

A complete loss of C1r or C1s function generally increases your risk for two major clinical issues:

1. Increased Risk of Infection

Without a fully working classical pathway, your body struggles to fight off certain bacteria, particularly encapsulated organisms like Streptococcus pneumoniae or Neisseria meningitidis [7]. These can cause serious, invasive illnesses:

  • Meningitis: Infection of the lining of the brain and spinal cord [1].
  • Sepsis: A life-threatening reaction to infection in the bloodstream [3].
  • Recurrent skin and respiratory infections: Such as pneumonia or abscesses, often beginning in early childhood [1].

2. Autoimmune Disease (SLE)

It may seem strange that an “underactive” immune system can cause an “overactive” autoimmune disease like Systemic Lupus Erythematosus (SLE). However, the C1 complex is responsible for clearing away “trash”—dead cells and bits of DNA [8]. If these aren’t cleared away, the immune system eventually treats them like invaders and begins attacking the body’s own tissues [9][7]. Lupus in people with this deficiency may be more likely to involve the kidneys (lupus nephritis) [1][10]. While not every person develops lupus or lupus nephritis, the risk is significantly higher.

Deficiency vs. Periodontal Ehlers-Danlos Syndrome (pEDS)

It is vital to distinguish complete C1r/C1s deficiency from a different condition called periodontal Ehlers-Danlos syndrome (pEDS). While they involve the same genes (C1R and C1S), they are biologically distinct and require formal genetic interpretation:

Feature Complete C1r/C1s Deficiency Periodontal EDS (pEDS)
Genetics Biallelic (you have two pathogenic copies of the gene) [1]. Usually Heterozygous (you have one mutated copy) [11].
Biology Loss-of-Function: The engine is missing or inactive [7]. Often involves abnormal protein behavior outside system control [12].
Classical Pathway Activity is absent or near zero (very low CH50) [1]. Activity is often preserved, but the proteins behave abnormally [13].
Main Symptoms Serious infections and Lupus-like autoimmunity [7]. Severe gum disease, typical tooth loss by age 20, and easy bruising [14][15].

Managing the Condition

Because this condition is so rare, there is no single “standard” treatment. Instead, care is tailored to your symptoms and risks:

  • Vaccination: Staying up to date on vaccines against encapsulated bacteria is critical to help other parts of your immune system pick up the slack [3].
  • Monitoring: Regular check-ups for lupus symptoms and kidney function can help catch autoimmune issues early [1].
  • Specialist Care: Most patients should be followed by a Clinical Immunologist or Rheumatologist who understands complement disorders [3].

If you have a confirmed deficiency, your doctor will likely use a specialized test called a CH50 to measure the classical pathway’s total function, alongside an AH50 to ensure the rest of your complement system is working correctly [3][1].

Common questions in this guide

What is C1r/C1s deficiency?
C1r/C1s deficiency is an exceptionally rare disorder of the complement system, a group of blood proteins that helps fight infection and clear dead cells. Complete loss of C1r or C1s disrupts the classical pathway, while the alternative and lectin pathways may still function.
What infections can happen with complete C1r/C1s deficiency?
People with complete deficiency may be more vulnerable to infections caused by encapsulated bacteria, including Streptococcus pneumoniae and Neisseria meningitidis. Illnesses can include recurrent pneumonia or skin infections and serious infections such as meningitis or sepsis, especially beginning in childhood.
Does C1r/C1s deficiency increase the risk of lupus?
Yes. When the C1 complex cannot clear dead cells and cell debris efficiently, the immune system may begin reacting against the body's own tissues, increasing the risk of systemic lupus erythematosus. Lupus nephritis may be more likely in affected people, but not everyone develops lupus.
What do CH50 and AH50 results mean?
CH50 measures the overall function of the classical complement pathway, which is expected to be very low or absent in complete C1r/C1s deficiency. AH50 assesses the alternative pathway and helps show whether that part of complement remains functional; your clinician must interpret both results with genetic and clinical information.
How is C1r/C1s deficiency different from periodontal Ehlers-Danlos syndrome?
The conditions can involve the same C1R or C1S genes but are biologically different. Complete C1r/C1s deficiency usually involves pathogenic changes in both gene copies and very low classical pathway activity, whereas periodontal Ehlers-Danlos syndrome usually involves one altered copy and is associated with severe gum disease, early tooth loss, and easy bruising.
How is complete C1r/C1s deficiency managed?
There is no single standard treatment because care is tailored to each person's infection and autoimmune risks. Management may include vaccines against encapsulated bacteria, regular monitoring for lupus and kidney problems, and follow-up with a clinical immunologist or rheumatologist.
Should family members be tested for a C1R or C1S variant?
Family testing may be appropriate when a C1R or C1S variant has been identified, because complete deficiency can result from pathogenic changes in both gene copies. Ask your healthcare team whether relatives need variant-specific testing and how the result should be interpreted.

Get notified when new evidence is published on complement component C1r/C1s deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (15)
  1. 1

    Complement C1s deficiency in a male Caucasian patient with systemic lupus erythematosus: a case report.

    Kleer JS, Skattum L, Dubler D, et al.

    Frontiers in immunology 2023; (14()):1257525 doi:10.3389/fimmu.2023.1257525.

    PMID: 38469558
  2. 2

    Headless C1q: a new molecular tool to decipher its collagen-like functions.

    Fouët G, Bally I, Signor L, et al.

    The FEBS journal 2021; (288(6)):2030-2041 doi:10.1111/febs.15543.

    PMID: 32869492
  3. 3

    Immunodeficiency: Complement disorders.

    McMurray JC, Schornack BJ, Weskamp AL, et al.

    Allergy and asthma proceedings 2024; (45(5)):305-309 doi:10.2500/aap.2024.45.240050.

    PMID: 39294906
  4. 4

    Functional Complement Analysis Can Predict Genetic Testing Results and Long-Term Outcome in Patients With Complement Deficiencies.

    Blazina Š, Debeljak M, Košnik M, et al.

    Frontiers in immunology 2018; (9()):500 doi:10.3389/fimmu.2018.00500.

    PMID: 29619023
  5. 5

    C1 Complex: An Adaptable Proteolytic Module for Complement and Non-Complement Functions.

    Lu J, Kishore U

    Frontiers in immunology 2017; (8()):592 doi:10.3389/fimmu.2017.00592.

    PMID: 28596769
  6. 6

    Proteolytic inactivation of nuclear alarmin high-mobility group box 1 by complement protease C1s during apoptosis.

    Yeo JG, Leong J, Arkachaisri T, et al.

    Cell death discovery 2016; (2()):16069 doi:10.1038/cddiscovery.2016.69.

    PMID: 27648302
  7. 7

    Complement C1s as a diagnostic marker and therapeutic target: Progress and propective.

    Ye J, Yang P, Yang Y, Xia S

    Frontiers in immunology 2022; (13()):1015128 doi:10.3389/fimmu.2022.1015128.

    PMID: 36275687
  8. 8

    Systemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical Pathway.

    Macedo AC, Isaac L

    Frontiers in immunology 2016; (7()):55 doi:10.3389/fimmu.2016.00055.

    PMID: 26941740
  9. 9

    C1q as a potential tolerogenic therapeutic in transplantation.

    Baldwin WM, Valujskikh A, Fairchild RL

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2021; (21(11)):3519-3523 doi:10.1111/ajt.16705.

    PMID: 34058061
  10. 10

    The axis of complement C1 and nucleolus in antinuclear autoimmunity.

    Wu S, Chen J, Teo BHD, et al.

    Frontiers in immunology 2023; (14()):1196544 doi:10.3389/fimmu.2023.1196544.

    PMID: 37359557
  11. 11

    Impact of a Heterozygous C1RR301P/WT Mutation on Collagen Metabolism and Inflammatory Response in Human Gingival Fibroblasts.

    Qu C, Koskinen Holm C

    Cells 2025; (14(7)) doi:10.3390/cells14070479.

    PMID: 40214433
  12. 12

    The yin and the yang of early classical pathway complement disorders.

    Sullivan KE

    Clinical and experimental immunology 2022; (209(2)):151-160 doi:10.1093/cei/uxac056.

    PMID: 35648651
  13. 13

    C1R Mutations Trigger Constitutive Complement 1 Activation in Periodontal Ehlers-Danlos Syndrome.

    Gröbner R, Kapferer-Seebacher I, Amberger A, et al.

    Frontiers in immunology 2019; (10()):2537 doi:10.3389/fimmu.2019.02537.

    PMID: 31749804
  14. 14

    Periodontal manifestations of Ehlers-Danlos syndromes: A systematic review.

    Kapferer-Seebacher I, Lundberg P, Malfait F, Zschocke J

    Journal of clinical periodontology 2017; (44(11)):1088-1100 doi:10.1111/jcpe.12807.

    PMID: 28836281
  15. 15

    Prospective clinical investigations of children with periodontal Ehlers-Danlos syndrome identify generalized lack of attached gingiva as a pathognomonic feature.

    Kapferer-Seebacher I, Oakley-Hannibal E, Lepperdinger U, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2021; (23(2)):316-322 doi:10.1038/s41436-020-00985-y.

    PMID: 33005042

This page explains C1r/C1s deficiency, its infection and lupus risks, and common tests for educational purposes only; it does not replace medical advice from your clinical immunologist or rheumatologist.